You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroblastoma

Showing 26 - 50 of 719
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)

Active, not recruiting
  • Neuroblastoma
  • iC9-GD2 T Cells - frozen
  • +5 more
  • Houston, Texas
  • +1 more
Jan 4, 2023

Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

Terminated
  • Neuroblastoma
  • antibody ch14.18
  • +4 more
  • Cologne, Germany
    University of Cologne
Nov 3, 2022

Neuroblastoma Trial in Lille, Lyon, Toulouse (PRRT with 177Lu-DOTATATE)

Not yet recruiting
  • Neuroblastoma
  • PRRT with 177Lu-DOTATATE
  • Lille, France
  • +2 more
Nov 8, 2022

High-risk Neuroblastoma Trial in Charlotte (Naxitamab, Ceritinib)

Not yet recruiting
  • High-risk Neuroblastoma
  • Charlotte, North Carolina
    Levine Children's Hospital
Aug 4, 2022

Recurrent Neuroblastoma Trial in Germany (metronomic therapy)

Recruiting
  • Recurrent Neuroblastoma
  • metronomic therapy
  • Bonn, Germany
  • +7 more
Nov 3, 2022

Neuroblastoma Recurrent Trial in Worldwide (Naxitamab and GM-CSF in combination with irinotecan and temozolomide)

Terminated
  • Neuroblastoma Recurrent
  • Naxitamab and GM-CSF in combination with irinotecan and temozolomide
  • Hong Kong, Hong Kong
  • +2 more
Nov 8, 2022

Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131

Available
  • Neuroblastoma
  • Childhood Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine (131 I-MIBG)
  • 131 I-MIBG
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jul 11, 2022

Olfactory Neuroblastoma, Esthesioneuroblastoma, Tumor of the Nasal Cavity Trial run by the NCI (Bintrafusp alfa / M7824)

Recruiting
  • Olfactory Neuroblastoma
  • +2 more
  • Bintrafusp alfa / M7824
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Neuroblastoma, Osteosarcoma Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Neuroblastoma
  • Osteosarcoma
  • iC9.GD2.CAR.IL-15 T-cells
  • +2 more
  • Atlanta, Georgia
  • +1 more
Jan 4, 2023

Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)

Active, not recruiting
  • Neuroblastoma
  • Hu3F8
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 1, 2022

Pediatric Neuroblastoma Treated With Lorlatinib

Completed
  • Neuroblastoma
  • Philadelphia, Pennsylvania
  • +10 more
Nov 17, 2022

Neuroblastoma Trial in United States (18F-MFBG)

Recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +7 more
Aug 18, 2022

Relapsed Neuroblastoma Trial in Grand Rapids (Cerebral Spinal (CS) radiation, Focal radiotherapy (SRS))

Withdrawn
  • Relapsed Neuroblastoma
  • Cerebral Spinal (CS) radiation
  • Focal radiotherapy (SRS)
  • Grand Rapids, Michigan
    Helen DeVos Children's Hospital
Apr 20, 2022

High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,

Recruiting
  • High Risk Neuroblastoma
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +10 more
Jan 19, 2023

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Brain Tumor, Kidney Tumor, Neuroblastoma Trial in Villejuif (Skin biopsy, Fresh tumor sample, Blood sample)

Recruiting
  • Brain Tumor
  • +3 more
  • Skin biopsy
  • +4 more
  • Villejuif, France
    Gustave Roussy
May 26, 2023

Neuroblastoma, Relapsed Neuroblastoma, Refractory Neuroblastoma Trial in United States (67Cu-SARTATE, 64Cu-SARTATE)

Recruiting
  • Neuroblastoma
  • +2 more
  • Phoenix, Arizona
  • +8 more
Jun 29, 2022

Refractory/Relapse Neuroblastoma, Pediatric Solid Tumors With Lung Metastases Trial in Fukuoka (Biological)

Recruiting
  • Refractory/Relapse Neuroblastoma
  • Pediatric Solid Tumors With Lung Metastases
  • Biological
  • Fukuoka, Japan
    Kyushu University Hospital
Nov 7, 2022

Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Jun 17, 2022

Outcome of Patients With Neuroblastoma: A Retrospective Study

Recruiting
  • Neuroblastoma
    • Assiut, Egypt
      Assiut University
    Apr 11, 2022

    Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,

    Recruiting
    • Recurrent Neuroblastoma
    • +3 more
    • Palo Alto, California
    • +3 more
    Jan 25, 2023

    Neuroblastoma Trial in Houston (Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN

    Active, not recruiting
    • Neuroblastoma
    • Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN neuroblastoma cells
    • Cytoxan
    • Houston, Texas
      Texas Children's Hospital
    Mar 25, 2022

    Neuroblastoma, Pheochromocytoma Trial in Memphis (18F-DA)

    Recruiting
    • Neuroblastoma
    • Pheochromocytoma
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Feb 15, 2022

    Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Dallas (131 I-Metaiodobenzylguanidine, Potassium Iodide, G-csf)

    No longer available
    • Relapsed Neuroblastoma
    • Metastatic Pheochromocytoma
    • 131 I-Metaiodobenzylguanidine
    • +2 more
    • Dallas, Texas
      The University of Texas Southwestern Medical Center
    Apr 13, 2022

    Relapsed Neuroblastoma Trial in Minsk (DNA vaccine, Salmonella oral vaccine, Lenalidomide)

    Recruiting
    • Relapsed Neuroblastoma
    • DNA vaccine
    • +2 more
    • Minsk, Minsk Region, Belarus
      Belarussian Research Center for Pediatric Oncology, Hematology a
    Mar 1, 2022